AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 187 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $302,000 | -41.4% | 8,675 | -58.7% | 0.09% | -19.6% |
| Q3 2016 | $515,000 | +2.6% | 21,001 | 0.0% | 0.11% | -14.4% |
| Q2 2016 | $502,000 | +2.2% | 21,001 | 0.0% | 0.12% | -17.8% |
| Q1 2016 | $491,000 | +31.3% | 21,001 | +123.0% | 0.15% | +53.5% |
| Q3 2015 | $374,000 | -60.0% | 9,416 | -30.5% | 0.10% | -43.8% |
| Q2 2015 | $935,000 | +40.8% | 13,542 | +11.4% | 0.18% | +50.4% |
| Q1 2015 | $664,000 | -23.4% | 12,154 | -40.2% | 0.12% | -15.8% |
| Q4 2014 | $867,000 | +33.6% | 20,335 | 0.0% | 0.14% | +67.5% |
| Q3 2014 | $649,000 | +164.9% | 20,335 | +72.0% | 0.08% | +219.2% |
| Q2 2014 | $245,000 | +7.0% | 11,822 | 0.0% | 0.03% | 0.0% |
| Q1 2014 | $229,000 | -20.2% | 11,822 | 0.0% | 0.03% | -27.8% |
| Q4 2013 | $287,000 | -38.7% | 11,822 | -45.7% | 0.04% | -52.6% |
| Q3 2013 | $468,000 | +40.5% | 21,772 | +45.5% | 0.08% | +15.2% |
| Q2 2013 | $333,000 | – | 14,967 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |